Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Factor Xa Inhibitors | 5 | 2020 | 490 | 1.48 | Why? |
| Anticoagulants | 22 | 2021 | 9563 | 1.27 | Why? |
| Thiazoles | 2 | 2020 | 496 | 1.11 | Why? |
| Pyridines | 2 | 2020 | 680 | 1.02 | Why? |
| Dabigatran | 2 | 2020 | 204 | 0.87 | Why? |
| Hemorrhage | 8 | 2020 | 3013 | 0.77 | Why? |
| Pyridones | 2 | 2020 | 738 | 0.66 | Why? |
| Kidney Function Tests | 1 | 2019 | 520 | 0.64 | Why? |
| Antithrombins | 1 | 2020 | 353 | 0.63 | Why? |
| Administration, Oral | 8 | 2020 | 2340 | 0.56 | Why? |
| Drug Monitoring | 4 | 2020 | 1408 | 0.56 | Why? |
| Pyrazoles | 2 | 2020 | 1791 | 0.47 | Why? |
| Atrial Fibrillation | 5 | 2019 | 2320 | 0.47 | Why? |
| Hemostasis | 4 | 2021 | 811 | 0.43 | Why? |
| Venous Thrombosis | 3 | 2021 | 2739 | 0.42 | Why? |
| Warfarin | 4 | 2018 | 402 | 0.42 | Why? |
| Vitamin K | 4 | 2019 | 263 | 0.35 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.33 | Why? |
| Rivaroxaban | 2 | 2018 | 467 | 0.27 | Why? |
| Drug Interactions | 2 | 2020 | 1653 | 0.24 | Why? |
| Infusions, Parenteral | 1 | 2020 | 41 | 0.21 | Why? |
| Gastrointestinal Hemorrhage | 2 | 2017 | 669 | 0.21 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.21 | Why? |
| Blood Coagulation Tests | 3 | 2020 | 855 | 0.20 | Why? |
| Acute Generalized Exanthematous Pustulosis | 1 | 2021 | 96 | 0.20 | Why? |
| Factor Xa | 1 | 2018 | 113 | 0.17 | Why? |
| Cytochrome P-450 CYP2C9 | 1 | 2016 | 25 | 0.17 | Why? |
| Thrombosis | 4 | 2021 | 7504 | 0.17 | Why? |
| Vitamin K Epoxide Reductases | 1 | 2016 | 32 | 0.17 | Why? |
| Galectin 3 | 1 | 2017 | 76 | 0.17 | Why? |
| Ventricular Fibrillation | 1 | 2018 | 126 | 0.17 | Why? |
| Thromboembolism | 3 | 2018 | 2101 | 0.16 | Why? |
| Darunavir | 1 | 2020 | 477 | 0.16 | Why? |
| Blood Coagulation Factors | 1 | 2018 | 223 | 0.16 | Why? |
| Pneumonia, Viral | 11 | 2020 | 243684 | 0.16 | Why? |
| von Willebrand Diseases | 1 | 2017 | 81 | 0.15 | Why? |
| Aged, 80 and over | 14 | 2021 | 88759 | 0.15 | Why? |
| In Vitro Techniques | 1 | 2019 | 1027 | 0.15 | Why? |
| Italy | 8 | 2020 | 38444 | 0.15 | Why? |
| Population Groups | 1 | 2017 | 212 | 0.14 | Why? |
| Blood Coagulation | 2 | 2018 | 2768 | 0.14 | Why? |
| Societies, Scientific | 1 | 2017 | 414 | 0.13 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.13 | Why? |
| Venous Thromboembolism | 3 | 2021 | 4273 | 0.13 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.13 | Why? |
| Colonic Neoplasms | 1 | 2017 | 295 | 0.12 | Why? |
| Prospective Studies | 9 | 2020 | 43301 | 0.12 | Why? |
| Intracranial Thrombosis | 1 | 2017 | 339 | 0.12 | Why? |
| Heart Valve Prosthesis Implantation | 1 | 2018 | 552 | 0.12 | Why? |
| Antiphospholipid Syndrome | 1 | 2018 | 533 | 0.12 | Why? |
| Gastrointestinal Tract | 1 | 2020 | 1113 | 0.11 | Why? |
| Enoxaparin | 1 | 2019 | 1064 | 0.11 | Why? |
| Intracranial Hemorrhages | 2 | 2017 | 1170 | 0.11 | Why? |
| Ambulatory Care Facilities | 2 | 2020 | 2063 | 0.11 | Why? |
| Aged | 18 | 2021 | 215776 | 0.11 | Why? |
| Thrombophilia | 2 | 2020 | 1935 | 0.11 | Why? |
| Anesthesia | 1 | 2021 | 1236 | 0.11 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.10 | Why? |
| Decision Support Techniques | 1 | 2017 | 903 | 0.10 | Why? |
| Humans | 35 | 2021 | 930598 | 0.09 | Why? |
| Skin | 1 | 2021 | 2096 | 0.09 | Why? |
| Female | 21 | 2021 | 380317 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.09 | Why? |
| Male | 19 | 2021 | 367725 | 0.09 | Why? |
| Crohn Disease | 1 | 2017 | 959 | 0.09 | Why? |
| Risk Assessment | 4 | 2020 | 25439 | 0.09 | Why? |
| Thrombocytopenia | 1 | 2021 | 2093 | 0.08 | Why? |
| Thrombolytic Therapy | 1 | 2019 | 2218 | 0.08 | Why? |
| Risk Factors | 10 | 2021 | 71621 | 0.08 | Why? |
| International Normalized Ratio | 2 | 2018 | 300 | 0.08 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.07 | Why? |
| Registries | 4 | 2018 | 12327 | 0.07 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.07 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.07 | Why? |
| Ultrasonography | 1 | 2020 | 4409 | 0.07 | Why? |
| Pregnancy Outcome | 1 | 2017 | 3803 | 0.07 | Why? |
| Stroke | 2 | 2017 | 8839 | 0.07 | Why? |
| Treatment Outcome | 6 | 2021 | 51732 | 0.06 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.06 | Why? |
| Heart Valve Prosthesis | 2 | 2018 | 533 | 0.06 | Why? |
| Myocardial Infarction | 1 | 2017 | 3361 | 0.06 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.05 | Why? |
| Biological Variation, Individual | 1 | 2020 | 66 | 0.05 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.05 | Why? |
| Pandemics | 10 | 2020 | 389249 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2019 | 4775 | 0.05 | Why? |
| Plasminogen Activator Inhibitor 1 | 1 | 2020 | 162 | 0.05 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.05 | Why? |
| Critical Care | 2 | 2021 | 14081 | 0.05 | Why? |
| Maximum Allowable Concentration | 1 | 2018 | 5 | 0.05 | Why? |
| Predictive Value of Tests | 3 | 2021 | 9537 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.05 | Why? |
| Ecology | 1 | 2019 | 140 | 0.04 | Why? |
| Acenocoumarol | 1 | 2017 | 22 | 0.04 | Why? |
| Thrombin | 1 | 2020 | 325 | 0.04 | Why? |
| Galectins | 1 | 2017 | 109 | 0.04 | Why? |
| Recurrence | 2 | 2017 | 3675 | 0.04 | Why? |
| Cerebral Veins | 1 | 2017 | 81 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Laboratories, Hospital | 1 | 2020 | 489 | 0.04 | Why? |
| Fibrinolysis | 1 | 2020 | 521 | 0.04 | Why? |
| Occult Blood | 1 | 2017 | 275 | 0.03 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.03 | Why? |
| Blood Proteins | 1 | 2017 | 551 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.03 | Why? |
| Biopsy | 1 | 2021 | 2811 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Cohort Studies | 3 | 2020 | 36005 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2018 | 23402 | 0.03 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.03 | Why? |
| History, 20th Century | 1 | 2017 | 1282 | 0.03 | Why? |
| Colonoscopy | 1 | 2017 | 738 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.02 | Why? |
| History, 21st Century | 1 | 2017 | 1849 | 0.02 | Why? |
| Endoscopy, Gastrointestinal | 1 | 2020 | 1545 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2020 | 1956 | 0.02 | Why? |
| Drug Prescriptions | 1 | 2017 | 1062 | 0.02 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2018 | 1671 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Medication Adherence | 1 | 2017 | 1270 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2021 | 7220 | 0.02 | Why? |
| Pregnancy Complications | 1 | 2017 | 1388 | 0.02 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
| Genotype | 1 | 2016 | 4697 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| Adult | 5 | 2020 | 244371 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2016 | 3607 | 0.02 | Why? |
| Surgical Procedures, Operative | 1 | 2018 | 2662 | 0.01 | Why? |
| Retrospective Studies | 3 | 2018 | 105322 | 0.01 | Why? |
| Disease Management | 1 | 2019 | 6841 | 0.01 | Why? |
| Percutaneous Coronary Intervention | 1 | 2017 | 3646 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.01 | Why? |
| Adolescent | 2 | 2017 | 86841 | 0.01 | Why? |
| Heart Failure | 1 | 2017 | 6638 | 0.01 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |
Testa's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(147)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(122)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_